"Trump May Announce Emergency Approval for COVID-19 Plasma Treatment"

WP Report.."Seeking Reversal Before Republican National Convention"
UK-Developed Vaccine May Bypass US Approval Standards for Possible Pre-Election Use

[Image source=AP Yonhap News]

[Asia Economy New York=Correspondent Baek Jong-min] Reports emerged on the 23rd (local time) that U.S. President Donald Trump is expected to announce the Emergency Use Authorization by the U.S. Food and Drug Administration (FDA) for convalescent plasma treatment for COVID-19 during a briefing.

The Washington Post (WP), citing officials, reported that President Trump, who views securing COVID-19 vaccines and treatments as key to winning the presidential election, will make this announcement the day before the Republican National Convention. The Republican National Convention will be held from the 24th to the 27th, the day after President Trump's briefing.

WP pointed out that plasma has long been used to treat infectious diseases including Ebola, but it is not certain whether it is effective for COVID-19 treatment as rigorous clinical trial results have not yet been produced.

On the same day, reports from the UK stated that President Trump is considering a plan to bypass U.S. health authorities' approval standards to introduce the COVID-19 vaccine being developed by Oxford University before the November presidential election.

This is also interpreted as an effort to secure a COVID-19 preventive vaccine before the election and use it advantageously in the election campaign.

This content was produced with the assistance of AI translation services.